Screen · Berkshire Criteria

Buffett Quality Screen

Buffett's "wonderful business" criteria, quantified into six dimensions: earnings record (20), ROE quality (25 — Fortune's double standard), low leverage (15), pricing power (15), business stability (15) and capital efficiency (10), for a 0–100 total. The entry gate is the first of Berkshire's acquisition criteria — at least $50M average pre-tax earnings over the last three fiscal years (banks and insurers excluded, as leverage is their business model; investment trusts and closed-end funds excluded, as they are portfolios rather than operating companies). Recomputed periodically from each company's last ten fiscal years; cross-listings merged by canonical ticker. Hover the score for the six-dimension breakdown; companies we cover link to their report. Отфильтровано по market cap "Mid $2–10B", profit streak "≥5 yr", No report yet: 516 match(сбросить фильтры) · страница 1 из 6.

#	Тикер	Mkt Cap	Score▼	Baillie	10Y ROE	Profit Streak	Net Debt/Eq	Gross Margin	Отчёт	FY
1	Rightmove PLC RMV · LSE	$4.4B	94/100 Элита	—	60.0%low 60.0%	10 yr+	Net cash	100%	—	FY2025
2	Nemetschek AG O.N. NEM · XETRA	$7.2B	93/100 Элита	—	26.3%low 19.4%	10 yr+	0.2×	53%	—	FY2025
3	MarketAxess Holdings Inc MKTX · США	$5.7B	93/100 Элита	—	25.1%low 19.7%	10 yr+	Net cash	77%	—	FY2025
4	Shenzhen New Industries Biomedical 300832 · Шэньчжэнь	$5.3B	93/100 Элита	—	23.5%low 17.4%	10 yr+	Net cash	75%	—	FY2025
5	Proya Cosmetics Co Ltd Class A 603605 · Шанхай	$3.3B	93/100 Элита	—	22.1%low 13.8%	10 yr+	Net cash	66%	—	FY2025
6	Genpact Limited G · США	$5.1B	92/100 Элита	—	20.4%low 16.8%	10 yr+	0.2×	36%	—	FY2025
7	Zhejiang Weixing New Building Materials Co Ltd 002372 · Шэньчжэнь	$2.0B	92/100 Элита	—	23.9%low 15.2%	10 yr+	Net cash	43%	—	FY2025
8	Jiangsu King's Luck Brewery Joint-Stock Co Ltd 603369 · Шанхай	$5.0B	91/100 Элита	—	19.7%low 15.7%	10 yr+	Net cash	74%	—	FY2025
9	Hubei Jumpcan Pharmaceutical Co Ltd 600566 · Шанхай	$3.4B	91/100 Элита	—	21.6%low 12.2%	10 yr+	Net cash	83%	—	FY2025
10	IMI PLC IMI · LSE	$8.8B	90/100 Элита	—	24.4%low 21.3%	10 yr+	0.5×	45%	—	FY2025
11	Chemed Corp CHE · США	$7.1B	90/100 Элита	—	29.2%low 18.2%	10 yr+	0.1×	33%	—	FY2025
12	Howden Joinery Group Plc HWDN · LSE	$5.5B	90/100 Элита	—	32.1%low 20.5%	10 yr+	0.3×	62%	—	FY2025
13	Ninety One PLC N91 · LSE	$2.7B	90/100 Элита	—	51.3%low 21.9%	10 yr+	Net cash	64%	—	FY2026
14	Hangzhou Robam Appliances Co Ltd 002508 · Шэньчжэнь	$2.1B	90/100 Элита	—	19.8%low 10.9%	10 yr+	Net cash	53%	—	FY2025
15	Yealink Network Technology Corp Ltd 300628 · Шэньчжэнь	$6.9B	89/100 Элита	—	28.7%low 20.6%	10 yr+	Net cash	67%	—	FY2025
16	MSC Industrial Direct Company Inc MSM · США	$6.9B	89/100 Элита	—	20.2%low 14.4%	10 yr+	0.3×	42%	—	FY2025
17	Gentex Corporation GNTX · США	$5.0B	89/100 Элита	—	18.6%low 15.4%	10 yr+	Net cash	36%	—	FY2025
18	Grand Canyon Education Inc LOPE · США	$3.8B	89/100 Элита	—	23.3%low 16.3%	10 yr+	Net cash	52%	—	FY2025
19	Anhui Gujing Distillery Co Ltd 000596 · Шэньчжэнь	$7.0B	88/100 Элита	—	18.6%low 13.9%	10 yr+	Net cash	77%	—	FY2025
20	Computacenter PLC CCC · LSE	$6.1B	88/100 Элита	—	20.0%low 14.9%	10 yr+	Net cash	14%	—	FY2025
21	Qualys Inc QLYS · США	$5.1B	88/100 Элита	—	24.2%low 7.4%	10 yr+	Net cash	79%	—	FY2025
22	Rotork PLC ROR · LSE	$5.0B	88/100 Элита	—	16.4%low 12.2%	10 yr+	Net cash	46%	—	FY2025
23	Cohen & Steers Inc CNS · США	$4.2B	88/100 Элита	—	40.2%low 27.3%	10 yr+	Net cash	50%	—	FY2025
24	Toro Co TTC · США	$8.7B	87/100 Элита	—	32.6%low 21.8%	10 yr+	0.5×	35%	—	FY2025
25	Brady Corporation BRC · США	$4.5B	87/100 Элита	—	14.9%low 12.1%	10 yr+	Net cash	50%	—	FY2025
26	Anhui Yingjia Distillery Co Ltd 603198 · Шанхай	$4.4B	87/100 Элита	—	21.0%low 16.2%	10 yr+	Net cash	66%	—	FY2025
27	HLA GROUP CORP LTD 600398 · Шанхай	$4.2B	87/100 Элита	—	19.8%low 11.8%	10 yr+	Net cash	39%	—	FY2025
28	Plus500 Ltd PLUS · LSE	$3.3B	87/100 Элита	—	52.0%low 38.8%	10 yr+	Net cash	100%	—	FY2025
29	Indutrade AB INDT · ST	$9.3B	86/100 Элита	—	19.6%low 15.0%	10 yr+	0.4×	34%	—	FY2025
30	Hebei Yangyuan ZhiHui Beverage Co Ltd 603156 · Шанхай	$6.8B	86/100 Элита	—	21.0%low 12.8%	10 yr+	Net cash	48%	—	FY2025
31	Zhejiang Supor Co Ltd 002032 · Шэньчжэнь	$4.8B	86/100 Элита	—	28.8%low 23.7%	10 yr+	Net cash	26%	—	FY2025
32	RS GROUP PLC RS1 · LSE	$4.3B	86/100 Элита	—	19.3%low 11.3%	10 yr+	0.2×	43%	—	FY2026
33	Livzon Pharmaceutical Group Inc 000513 · Шэньчжэнь	$3.9B	86/100 Элита	—	16.0%low 10.2%	10 yr+	Net cash	63%	—	FY2025
34	YETI Holdings Inc YETI · США	$3.7B	86/100 Элита	—	35.8%low 17.0%	10 yr+	0.1×	53%	—	FY2025
35	Shanghai M&G Stationery Inc 603899 · Шанхай	$3.0B	86/100 Элита	—	20.8%low 14.1%	10 yr+	Net cash	23%	—	FY2025
36	Buckle Inc BKE · США	$2.3B	86/100 Элита	—	39.8%low 22.8%	10 yr+	0.3×	46%	—	FY2026
37	IG Group Holdings PLC IGG · LSE	$6.1B	85/100 Элита	—	22.8%low 16.3%	10 yr+	Net cash	90%	—	FY2025
38	Vontier Corp VNT · США	$4.5B	85/100 Элита	—	40.2%low 21.4%	10 yr+	1.3×	45%	—	FY2025
39	Acuity Brands Inc AYI · США	$9.8B	84/100 Элита	—	17.1%low 11.7%	10 yr+	0.2×	43%	—	FY2025
40	Elisa Oyj ELISA · HE	$6.1B	84/100 Элита	—	28.4%low 26.4%	10 yr+	1.2×	62%	—	FY2025
41	Fuchs Petrolub SE Preference Shares FPE3 · XETRA	$5.7B	84/100 Элита	—	16.6%low 13.9%	10 yr+	Net cash	34%	—	FY2025
42	G-bits Network Technology Xiamen Co Ltd 603444 · Шанхай	$3.9B	84/100 Элита	—	28.1%low 19.3%	10 yr+	Net cash	90%	—	FY2025
43	Jiangzhong Pharmaceutical Co Ltd 600750 · Шанхай	$2.3B	84/100 Элита	—	15.8%low 12.2%	10 yr+	Net cash	66%	—	FY2025
44	Jafron Biomedical Co Ltd 300529 · Шэньчжэнь	$2.1B	84/100 Элита	—	23.3%low 13.9%	10 yr+	Net cash	83%	—	FY2025
45	Huadong Medicine Co Ltd 000963 · Шэньчжэнь	$7.1B	83/100 Элита	—	17.6%low 13.5%	10 yr+	Net cash	30%	—	FY2025
46	Morgan Sindall Group PLC MGNS · LSE	$2.6B	83/100 Элита	—	17.5%low 10.8%	10 yr+	Net cash	11%	—	FY2025
47	Landstar System Inc LSTR · США	$5.9B	82/100 Элита	—	30.3%low 14.5%	10 yr+	Net cash	20%	—	FY2025
48	Trex Company Inc TREX · США	$4.5B	82/100 Элита	—	33.1%low 18.4%	10 yr+	0.2×	40%	—	FY2025
49	Chongqing Brewery Co Ltd 600132 · Шанхай	$3.1B	82/100 Элита	—	49.8%low 14.7%	10 yr+	Net cash	46%	—	FY2025
50	Dashenlin Pharm Grp Co Ltd 603233 · Шанхай	$3.0B	82/100 Элита	—	18.2%low 13.3%	10 yr+	0.0×	38%	—	FY2025
51	CSG Systems International Inc CSGS · США	$2.3B	82/100 Элита	—	20.0%low 12.4%	10 yr+	1.4×	48%	—	FY2025
52	Demant A/S DEMANT · CO	$9.2B	81/100 Элита	—	21.9%low 13.6%	10 yr+	2.3×	74%	—	FY2025
53	Spirax Group plc SPX · LSE	$6.5B	81/100 Элита	—	20.6%low 13.4%	10 yr+	0.5×	50%	—	FY2025
54	Shanghai Friendess Electronics Tech 688188 · Шанхай	$5.9B	81/100 Элита	—	27.3%low 11.2%	10 yr+	Net cash	82%	—	FY2025
55	Huali Industrial Group Company Limited 300979 · Шэньчжэнь	$5.8B	81/100 Элита	—	30.9%low 19.7%	9 yr	Net cash	23%	—	FY2025
56	Temenos Group AG TEMN · SW	$5.7B	81/100 Элита	—	36.0%low 19.7%	10 yr+	1.2×	70%	—	FY2025
57	Hisense Kelon Electrical Holdings Co Ltd 000921 · Шэньчжэнь	$5.3B	81/100 Элита	—	19.1%low 9.4%	10 yr+	Net cash	21%	—	FY2025
58	Lancaster Colony Corporation LANC · США	$4.8B	81/100 Элита	—	17.8%low 10.6%	10 yr+	Net cash	24%	—	FY2024
59	Royal Unibrew A/S RBREW · CO	$3.6B	81/100 Элита	—	29.8%low 19.1%	10 yr+	0.9×	48%	—	FY2025
60	Shanghai Huace Navigation Technology Ltd 300627 · Шэньчжэнь	$3.2B	81/100 Элита	—	17.0%low 12.2%	10 yr+	Net cash	60%	—	FY2025
61	The Marzetti Company MZTI · США	$2.9B	81/100 Элита	—	17.7%low 10.6%	10 yr+	Net cash	24%	—	FY2025
62	AIMA Technology Group Co Ltd 603529 · Шанхай	$2.7B	81/100 Элита	—	25.4%low 13.3%	10 yr+	Net cash	15%	—	FY2025
63	Dino Polska SA DNP · WAR	$8.6B	80/100 Элита	—	24.2%low 18.0%	10 yr+	Net cash	24%	—	FY2025
64	Edenred SA EDEN · Париж	$7.3B	80/100 Элита	—	60.0%^‡low 60.0%	10 yr+	—	48%	—	FY2025
65	China Resources Sanjiu Medical & Pharmaceutical Co Ltd 000999 · Шэньчжэнь	$6.0B	80/100 Элита	—	14.4%low 11.6%	10 yr+	Net cash	60%	—	FY2025
66	Auto Trader Group plc AUTO · LSE	$5.2B	80/100 Элита	—	51.1%low 27.9%	10 yr+	0.5×	91%	—	FY2026
67	Frontdoor Inc FTDR · США	$5.1B	80/100 Элита	—	49.5%low 22.1%	10 yr+	2.7×	47%	—	FY2025
68	Badger Meter Inc BMI · США	$3.9B	80/100 Элита	—	15.1%low 9.2%	10 yr+	Net cash	39%	—	FY2025
69	Jiangsu Nhwa Pharmaceutical Co Ltd 002262 · Шэньчжэнь	$3.1B	80/100 Элита	—	16.2%low 13.1%	10 yr+	Net cash	66%	—	FY2025
70	Artisan Partners Asset Management Inc APAM · США	$2.8B	80/100 Элита	—	58.6%low 45.9%	10 yr+	0.4×	49%	—	FY2025
71	Pandora A/S PNDORA · CO	$9.4B	79/100 Сильный	—	56.2%low 26.2%	10 yr+	3.4×	76%	—	FY2025
72	Cirrus Logic Inc CRUS · США	$6.5B	79/100 Сильный	—	15.6%low 7.9%	10 yr+	Net cash	51%	—	FY2026
73	HEXPOL AB (publ) HPOL-B · ST	$3.3B	79/100 Сильный	—	17.4%low 13.9%	10 yr+	0.2×	21%	—	FY2025
74	LeMaitre Vascular Inc LMAT · США	$2.3B	79/100 Сильный	—	12.6%low 7.7%	10 yr+	Net cash	68%	—	FY2025
75	Top Choice Medical Investment Co Inc 600763 · Шанхай	$2.3B	79/100 Сильный	—	19.1%low 11.9%	10 yr+	0.2×	42%	—	FY2025
76	Dunelm Group PLC DNLM · LSE	$2.3B	79/100 Сильный	—	56.5%low 45.8%	10 yr+	2.9×	48%	—	FY2025
77	BeiJing DaHao Technology Co Lt 603025 · Шанхай	$2.1B	79/100 Сильный	—	19.2%low 11.8%	10 yr+	Net cash	44%	—	FY2025
78	Installed Building Products Inc IBP · США	$6.0B	78/100 Сильный	—	31.6%low 19.5%	10 yr+	1.0×	31%	—	FY2025
79	Amdocs Ltd DOX · США	$5.9B	78/100 Сильный	—	14.3%low 10.3%	10 yr+	0.1×	35%	—	FY2025
80	Softcat plc SCT · LSE	$4.8B	78/100 Сильный	—	48.1%low 38.0%	10 yr+	Net cash	28%	—	FY2025
81	Imeik Technology Development Co 300896 · Шэньчжэнь	$4.6B	78/100 Сильный	—	24.5%low 9.7%	10 yr+	Net cash	92%	—	FY2025
82	Doximity Inc DOCS · США	$3.8B	78/100 Сильный	—	27.9%low 11.7%	8 yr	Net cash	88%	—	FY2026
83	China National Medicines Corp Ltd 600511 · Шанхай	$3.0B	78/100 Сильный	—	14.8%low 10.8%	10 yr+	Net cash	8%	—	FY2025
84	Academy Sports Outdoors Inc ASO · США	$2.9B	78/100 Сильный	—	33.8%low 17.4%	9 yr	0.7×	32%	—	FY2026
85	Alpha Group International plc ALPH · LSE	$2.3B	78/100 Сильный	—	30.6%low 14.3%	10 yr+	Net cash	78%	—	FY2024
86	Xp Inc XP · США	$8.8B	77/100 Сильный	—	22.6%low 14.7%	10 yr+	3.2×	67%	—	FY2025
87	Biomerieux SA BIM · Париж	$8.8B	77/100 Сильный	—	12.8%low 9.5%	10 yr+	Net cash	55%	—	FY2025
88	ExlService Holdings Inc EXLS · США	$5.2B	77/100 Сильный	—	15.6%low 8.2%	10 yr+	0.1×	36%	—	FY2025
89	Hengan Intl Group Ltd-H 1044 · Гонконг	$3.6B	77/100 Сильный	—	18.0%low 9.9%	10 yr+	0.0×	38%	—	FY2025
90	Jason Furniture(Hangzhou) 603816 · Шанхай	$2.9B	77/100 Сильный	—	18.4%low 12.5%	10 yr+	Net cash	34%	—	FY2025
91	Autobio Diagnostics Co Ltd 603658 · Шанхай	$2.7B	77/100 Сильный	—	18.8%low 11.5%	10 yr+	Net cash	64%	—	FY2025
92	ePlus inc PLUS · США	$2.4B	77/100 Сильный	—	13.9%low 11.0%	10 yr+	Net cash	24%	—	FY2026
93	China Resources Double-Crane Pharmaceutical Co Ltd 600062 · Шанхай	$2.4B	77/100 Сильный	—	12.3%low 9.4%	10 yr+	Net cash	58%	—	FY2025
94	Hamilton Lane Inc HLNE · США	$6.0B	76/100 Сильный	—	25.3%low 0.7%	10 yr+	Net cash	67%	—	FY2026
95	Fortune Brands Innovations Inc. FBIN · США	$5.9B	76/100 Сильный	—	19.9%low 12.5%	10 yr+	1.0×	40%	—	FY2025
96	Hangcha Group Co Ltd 603298 · Шанхай	$5.2B	76/100 Сильный	—	16.3%low 12.6%	10 yr+	Net cash	20%	—	FY2025
97	Atmus Filtration Technologies Inc. ATMU · США	$4.2B	76/100 Сильный	—	47.2%low 31.9%	7 yr	0.9×	26%	—	FY2025
98	TriNet Group Inc TNET · США	$3.0B	76/100 Сильный	—	52.5%low 38.4%	10 yr+	12.1×	19%	—	FY2025
99	Joincare Pharmaceutical Group Industry Co Ltd 600380 · Шанхай	$2.6B	76/100 Сильный	—	11.5%low 7.3%	10 yr+	Net cash	62%	—	FY2025
100	Neway Valve suzhou Co Ltd 603699 · Шанхай	$4.9B	75/100 Сильный	—	17.1%low 8.2%	10 yr+	Net cash	34%	—	FY2025

Data and methodology: the six dimensions quantify Berkshire's published acquisition criteria and Buffett's shareholder letters (1981/1987/1991/2007 among others). Qualitative tests in the originals (e.g. "simple, understandable business", "management in place") are out of scope, and price ("available at a fair price") is covered by each report's valuation range instead. Financials come from company annual reports (via EODHD); ratios are computed in reporting currency, the USD gate via static FX. "‡" marks companies whose equity is persistently negative or tiny (ROE falls back to ROCE); "†" marks missing gross profit (operating margin used). Investment trusts and closed-end funds are excluded on two tests — name and financial shape (operating margins beyond what an operating company can achieve); REITs and operating asset managers are unaffected. This is a quantitative first pass, not investment advice. When citing this data, please credit Zen Horizon (zh.app). See our methodology for the scoring process.